Oregon

Oregon

  • Visitors must have compliant masks

    Visitors must have compliant masks

    Some visitors are using masks from home that have been found ineffective.

    Read Article
  • Providence Head and Neck Cancer Surgeons Use New Transoral Robotic Technology to Improve Surgical Outcomes

    Providence Head and Neck Cancer Surgeons Use New Transoral Robotic Technology to Improve Surgical Outcomes

    Providence Cancer Institute head and neck surgeons are some of a few nationwide, that are using a new transoral robotic technology for surgical treatment of head and neck cancers.

    Read Article
  • Providence Offers Breakthrough Radiation Technology to Cancer Patients

    Providence Offers Breakthrough Radiation Technology to Cancer Patients

    Providence Cancer Institute now offers cancer patients the most cutting-edge radiation technology in the world.

    Read Article
  • ×

    Zip Code
    Thank you for subscribing!
    Error - something went wrong!
  • GET THE APP ›
  • New phase I immuno-oncology study for HPV16+ cancers

    New phase I immuno-oncology study for HPV16+ cancers

    An unmet clinical need exists for patients with cancers associated with human papillomavirus. A new phase I study at Providence Cancer Institute will evaluate a novel biologic therapy in patients with

    Read Article
  • Providence Hospitals Honored for Excellence in Patient Safety and Patient Experience

    Providence Hospitals Honored for Excellence in Patient Safety and Patient Experience

    Providence St. Vincent Medical Center is being recognized in the top 2% of more than 4,500 hospitals nationwide.

    Read Article
  • Cancer Immunotherapy Month

    Cancer Immunotherapy Month

    June is Cancer Immunotherapy MonthTM, an initiative to call attention to cancer immunotherapy, a specialized field focused on harnessing the power of the immune system to cure cancer.

    Read Article
  • Providence at forefront of COVID-19 clinical research

    Providence at forefront of COVID-19 clinical research

    The outbreak of coronavirus disease 2019 (COVID-19) brought about an unprecedented global threat to public health. Providence has been at the forefront of COVID-19 treatment and research in the United

    Read Article
  • Providence cancer researchers highlighted at ASCO20: Virtual

    Providence cancer researchers highlighted at ASCO20: Virtual

    Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in Portland, Oregon, will join oncology professionals around the world for the 2020 ASCO Virtual Scient

    Read Article
  • FIND A DOCTOR ›
  • Can you help sew masks? There is a need and we would appreciate your help.

    Can you help sew masks? There is a need and we would appreciate your help.

    If you know how to sew, you can help us provide safe care in our hospitals and clinics by sewing and donating cloth face masks.

    Read Article
  • Establishing and maintaining Providence St. Vincent’s excellence

    Establishing and maintaining Providence St. Vincent’s excellence

    Sister Rita helped the lead the charge to establish the St. Vincent Medical Center we know now.

    Read Article
  • Remembering Sister Rita Ferschweiler

    Remembering Sister Rita Ferschweiler

    Lisa Vance, Chief Executive, Providence Oregon shares the sad news of Sister Rita's passing

    Read Article
  • Providence COVID-19 news round-up for 3/19/20

    Providence COVID-19 news round-up for 3/19/20

    Learn more about the coronavirus or COVID-19 from Providence leaders

    Read Article
  • LEARN MORE
  • Early Phase Immunotherapy Studies for High-Risk Skin Cancers

    Early Phase Immunotherapy Studies for High-Risk Skin Cancers

    Providence Cancer Institute is one of a handful of centers offering two early phase studies evaluating combination immunotherapy for patients with rare and high-risk skin cancers.

    Read Article
  • New Immunotherapy Approaches for Cutaneous Squamous Cell Carcinoma

    New Immunotherapy Approaches for Cutaneous Squamous Cell Carcinoma

    Is checkpoint immunotherapy better with oncolytic viral therapy in patients with advanced cutaneous squamous cell carcinoma?

    Read Article
  • FIND A CLINIC ›
  • Clinical trials offer new options for advanced prostate cancer

    Clinical trials offer new options for advanced prostate cancer

    Recent research has opened up new treatment options for men with advanced prostate cancer.

    Read Article
  • Family tradition warms hearts of tens of thousands Christmas Day

    Family tradition warms hearts of tens of thousands Christmas Day

    Dr. Gary Ott and his family make an annual musical Christmas Day visit to the cardiac units at Providence St. Vincent

    Read Article
  • New studies aim to improve survival for patients with HER2+ breast cancer

    New studies aim to improve survival for patients with HER2+ breast cancer

    Providence Cancer Institute medical oncologists Alison Conlin, M.D., and David Page, M.D., oversee a vast portfolio of clinical trials

    Read Article
  • Elsie Franz Finley: Agent of Change, Friend of Providence

    Elsie Franz Finley: Agent of Change, Friend of Providence

    In recognition of her decades of support, Providence Portland Medical Center has named the radiation oncology department: The Elsie Franz Finley Radiation Oncology Center

    Read Article
  • New probody immuno-oncology study for solid tumors

    New probody immuno-oncology study for solid tumors

    A new study in the Robert W. Franz Cancer Center, tests the anticancer effects of an experimental probody therapeutic in patients with solid cancers

    Read Article
  • ×

    Zip Code
    Thank you for subscribing!
    Error - something went wrong!
  • New studies offer novel therapies for patients with GI cancers

    New studies offer novel therapies for patients with GI cancers

    Cancer center offers several studies of targeted therapies, immunotherapies and combination therapies for patients with GI cancers, including cancers of the biliary tract

    Read Article
  • loading
    Loading More...